Cargando…

Regulatory T-cell therapy approaches

Regulatory T cells (Tregs) have enormous therapeutic potential to treat a variety of immunopathologies characterized by aberrant immune activation. Adoptive transfer of ex vivo expanded autologous Tregs continues to progress through mid- to late-phase clinical trials in several disease spaces and ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	McCallion, Oliver, Bilici, Merve, Hester, Joanna, Issa, Fadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review Series: Therapeutic opportunities for regulatory T cell enhancing approaches (Series Editors: David F. Tough & Giovanna Lombardi)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019137/ https://www.ncbi.nlm.nih.gov/pubmed/35960852 http://dx.doi.org/10.1093/cei/uxac078

Ejemplares similares

IL-2-based approaches to Treg enhancement
por: Harris, Ffion, et al.
Publicado: (2022)

Treg specialization and functions beyond immune suppression
por: Astarita, Jillian L, et al.
Publicado: (2022)

Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves’ disease
por: Zala, Aakansha, et al.
Publicado: (2022)

The potential for Treg-enhancing therapies in transplantation
por: Steiner, Romy, et al.
Publicado: (2022)

From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics
por: Bending, D., et al.
Publicado: (2018)

Mechanisms of human FoxP3(+) T(reg) cell development and function in health and disease
por: Attias, M., et al.
Publicado: (2019)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Freezing Medium Containing 5% DMSO Enhances the Cell Viability and Recovery Rate After Cryopreservation of Regulatory T Cell Products ex vivo and in vivo
por: Kaiser, Daniel, et al.
Publicado: (2021)

Efficacy of attachment-based family therapy compared to treatment as usual for suicidal ideation in adolescents with MDD
por: Waraan, Luxsiya, et al.
Publicado: (2020)

Indian regulatory update 2013
por: Suvarnapathaki, Kedar
Publicado: (2013)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

FoxP3 in T(reg) cell biology: a molecular and structural perspective
por: Deng, G., et al.
Publicado: (2019)

Indian Regulatory Update: Jan-May 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: June-August 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: September-November 2013
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: January-March 2015
por: Suvarnapathaki, Kedar
Publicado: (2015)

Indian Regulatory Update: January-December 2017
por: Bhave, Amita
Publicado: (2018)

Indian Regulatory Update: January – March 2018
por: Bhave, Amita
Publicado: (2018)

Indian regulatory update April–October 2018
por: Bhave, Amita, et al.
Publicado: (2019)

Indian regulatory update during the COVID-19 pandemic
por: Bhave, Amita Chandan
Publicado: (2020)

Indian Regulatory Update-2 during the COVID-19 pandemic
por: Bhave, Amita
Publicado: (2020)

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
por: Casati, S., et al.
Publicado: (2017)

The management of benign non-infective pleural effusions
por: Bintcliffe, Oliver J., et al.
Publicado: (2016)

4349 Survey of Regulatory Reforms to Address Comprehension of Clinical Trial Results
por: Kirkland, Matthieu, et al.
Publicado: (2020)

Interleukin-6: obstacles to targeting a complex cytokine in critical illness
por: McElvaney, Oliver J, et al.
Publicado: (2021)

Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach
por: Ghigna, Maria-Rosa, et al.
Publicado: (2021)

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
por: Singh, Sally J, et al.
Publicado: (2023)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach
por: Kenyon, Chris, et al.
Publicado: (2023)

Pulmonary hypertension in chronic lung disease and hypoxia
por: Nathan, Steven D., et al.
Publicado: (2019)

Shrinking the malaria map: progress and prospects
por: Feachem, Richard GA, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4fbuj3qpdd9q8047joq1juer5e